Transcription of 07.291 Pneumococcal 13-valent Conjugate Vaccine Biological ...
{{id}} {{{paragraph}}}
Example: confidence
07.291 Pneumococcal 13-valent Conjugate Vaccine Biological ...
Alberta Health Services Standard # September 5, 2018 Immunization Program Standards Manual Page 1 of 9 Population, Public and Indigenous Health Pneumococcal 13 -valent Conjugate Vaccine Biological Page Section 7: Biological Product Information Standard #: Created by: Province-wide Immunization Program Standards and Quality Approved by: Province-wide Immunization Program Standards and Quality Approval Date: February 1, 2012 Revised: September 5, 2018 Prevnar 13 Manufacturer Wyeth, Pfizer Canada Inc. Biological Classification Inactivated Indications for Provincially Funded Vaccine Healthy Children: 2 months up to and including 59 months of age.
o Congenital immunodeficiencies involving any part of the immune system, including B-lymphocyte (humoral) immunity, T-lymphocyte (cell) mediated immunity, complement system (properdin or factor D deficiencies) or phagocytic functions. o HIV infection. o HSCT recipients. See Standard for Immunization of Transplant Candidates or Recipients #08.304.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: